Chinese english Germany Japanese Korea

Piperazine, 1-bicyclo[3.1.0]hex-3-yl-4-methyl-, (1-alpha-,3-ba-,5-alpha-)- (9CI)

Piperazine, 1-bicyclo[3.1.0]hex-3-yl-4-methyl-, (1-alpha-,3-ba-,5-alpha-)- (9CI) Struktur
79530-86-2
CAS-Nr.
79530-86-2
Englisch Name:
Piperazine, 1-bicyclo[3.1.0]hex-3-yl-4-methyl-, (1-alpha-,3-ba-,5-alpha-)- (9CI)
Synonyma:
1-[(1R,3R,5S)-BICYCLO[3.1.0]HEX-3-YL]-4-METHYLPIPERAZINE;Piperazine, 1-[(1α,3β,5α)-bicyclo[3.1.0]hex-3-yl]-4-methyl-;Piperazine, 1-bicyclo[3.1.0]hex-3-yl-4-methyl-, (1-alpha-,3-b;Piperazine,1-bicyclo[3.1.0]hex-3-yl-4-methyl-,(1-alpha-,3-bta-,5-alpha-)-(9CI);Piperazine, 1-bicyclo[3.1.0]hex-3-yl-4-methyl-, (1-alpha-,3-ba-,5-alpha-)- (9CI)
CBNumber:
CB11061395
Summenformel:
C11H20N2
Molgewicht:
180.29
MOL-Datei:
79530-86-2.mol
Request For Quotation

Piperazine, 1-bicyclo[3.1.0]hex-3-yl-4-methyl-, (1-alpha-,3-ba-,5-alpha-)- (9CI) Eigenschaften

Siedepunkt:
244.8±8.0 °C(Predicted)
Dichte
1.062±0.06 g/cm3(Predicted)
pka
8.35±0.70(Predicted)

Sicherheit

Piperazine, 1-bicyclo[3.1.0]hex-3-yl-4-methyl-, (1-alpha-,3-ba-,5-alpha-)- (9CI) Chemische Eigenschaften,Einsatz,Produktion Methoden

Piperazine, 1-bicyclo[3.1.0]hex-3-yl-4-methyl-, (1-alpha-,3-ba-,5-alpha-)- (9CI) Upstream-Materialien And Downstream Produkte

Upstream-Materialien

Downstream Produkte

Piperazine, 1-bicyclo[3.1.0]hex-3-yl-4-methyl-, (1-alpha-,3-ba-,5-alpha-)- (9CI) Anbieter Lieferant Produzent Hersteller Vertrieb Händler.

Global( 2)Lieferanten
Firmenname Telefon E-Mail Land Produktkatalog Edge Rate
Chempro Tech Co., Ltd. --
 China 6803 60
CHEMSTEP --
 info@chemstep.com Europe 6144 51
  • 1-[(1R,3R,5S)-BICYCLO[3.1.0]HEX-3-YL]-4-METHYLPIPERAZINE
  • Piperazine, 1-bicyclo[3.1.0]hex-3-yl-4-methyl-, (1-alpha-,3-ba-,5-alpha-)- (9CI)
  • Piperazine, 1-bicyclo[3.1.0]hex-3-yl-4-methyl-, (1-alpha-,3-b
  • Piperazine,1-bicyclo[3.1.0]hex-3-yl-4-methyl-,(1-alpha-,3-bta-,5-alpha-)-(9CI)
  • Piperazine, 1-[(1α,3β,5α)-bicyclo[3.1.0]hex-3-yl]-4-methyl-
  • 79530-86-2
  • CYCLOPENTANE
  • PIPERIDINE
Copyright 2019 © ChemicalBook. All rights reserved